DRNA Chart
- 52-Week Range: $19.26 - $39.99
- Market Capitalization: $2.96B
- Short Percentage: 0%
- Target Price: $38.25
- Shares Outstanding: 77.91M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Shares of RNAi Drug Companies Pop After Novo Lays Out $3.3 Billion for DicernaGuruFocus | November 22nd
- SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.PRNewsWire | November 18th
- DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing TodayInvestorPlace | November 18th
- Novo Nordisk strikes $3.3 billion to buy research partner Dicerna PharmaceuticalsMarket Watch | November 18th
- Dicerna Pharmaceuticals, Inc. (DRNA) CEO Doug Fambrough on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 9th
Company Info
Website: https://dicerna.com
Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
Sector: Healthcare
Industry: Biotechnology
Full time employees: 302
Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
Sector: Healthcare
Industry: Biotechnology
Full time employees: 302
$DRNA I love this stonk!
$DRNA just waiting ….
$DRNA Now I'm worried....
$DRNA I warned everyone this company sucks
$DRNA has just been halted from trading.
$DRNA to the moon
$DRNA Pack it up boys.
$DRNA has just been halted from trading.
$DRNA all’s I know is buy and hold… no expectations
$DRNA Nothing but time to wait